Marie Jeansson
Forskare
E-postadress: marie.jeansson@ki.se
Besöksadress: Novum, Blickagången 6, 14157 Huddinge/Stockholm
Postadress: H7 Medicin, Huddinge, H7 ICCA Betsholtz, 171 77 Stockholm
Artiklar
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2025;:e190286Jeansson M; Pietila R; Marks-Hultström A; He L; Nanavazdeah S; Quaggin S; Betsholtz C
- Journal article: NATURE. 2025;641(8062):465-475Schoofs H; Daubel N; Schnabellehner S; Gronloh MLB; Martinez SP; Halme A; Marks AM; Jeansson M; Barcos S; Brakebusch C; Benedito R; Engelhardt B; Vestweber D; Gaengel K; Linsenmeier F; Schurmann S; Saharinen P; van Buul JD; Friedrich O; Smith RS; Majda M; Makinen T
- Article: VASCULAR PHARMACOLOGY. 2024;157:107434Miao Y; Li W; Jeansson M; Mae MA; Muhl L; He L
- Article: NATURE COMMUNICATIONS. 2024;15(1):7643Uhrbom M; Muhl L; Genove G; Liu J; Palmgren H; Alexandersson I; Karlsson F; Zhou A-X; Lunnerdal S; Gustafsson S; Buyandelger B; Petkevicius K; Ahlstedt I; Karlsson D; Aasehaug L; He L; Jeansson M; Betsholtz C; Peng X-R
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024;25(8):4320Zhou A-X; Jeansson M; He L; Wigge L; Tonelius P; Tati R; Cederblad L; Muhl L; Uhrbom M; Liu J; Granqvist AB; Lerman LO; Betsholtz C; Hansen PBL
- Article: BIOMEDICINES. 2022;10(6):1333Hultstrom M; Fromell K; Larsson A; Persson B; Nilsson B; Quaggin SE; Betsholtz C; Frithiof R; Lipcsey M; Jeansson M
- Article: NATURE COMMUNICATIONS. 2021;12(1):2141He B; Chen P; Zambrano S; Dabaghie D; Hu Y; Moller-Hackbarth K; Unnersjoe-Jess D; Korkut GG; Charrin E; Jeansson M; Bintanel-Morcillo M; Witasp A; Wennberg L; Wernerson A; Schermer B; Benzing T; Ernfors P; Betsholtz C; Lal M; Sandberg R; Patrakka J
- Article: CIRCULATION RESEARCH. 2021;128(4):e46-e62Mae MA; He L; Nordling S; Vazquez-Liebanas E; Nahar K; Jung B; Li X; Tan BC; Foo JC; Cazenave-Gassiot A; Wenk MR; Zarb Y; Lavina B; Quaggin SE; Jeansson M; Gu C; Silver DL; Vanlandewijck M; Butcher EC; Keller A; Betsholtz C
- Article: PLOS ONE. 2018;13(1):e0189433Loganathan K; Said ES; Winterrowd E; Orebrand M; He L; Vanlandewijck M; Betsholtz C; Quaggin SE; Jeansson M
- Article: BMC CANCER. 2017;17(1):539Michael IP; Orebrand M; Lima M; Pereira B; Volpert O; Quaggin SE; Jeansson M
- Article: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2017;114:186-193Gruden S; Sandelin M; Rasanen V; Micke P; Hedeland M; Axen N; Jeansson M
- Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;25(11):2459-2470Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2014;124(10):4320-4324Thomson BR; Heinen S; Jeansson M; Ghosh AK; Fatima A; Sung H-K; Onay T; Chen H; Yamaguchi S; Economides AN; Flenniken A; Gale NW; Hong Y-K; Fawzi A; Liu X; Kume T; Quaggin SE
- Article: JOURNAL OF PATHOLOGY. 2013;230(1):95-106Hale LJ; Welsh GI; Perks CM; Hurcombe JA; Moore S; Hers I; Saleem MA; Mathieson PW; Murphy AJ; Jeansson M; Holly JM; Hardouin SN; Coward RJ
- Article: AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. 2013;304(1):F120-F126Ding M; Coward RJ; Jeansson M; Kim W; Quaggin SE
- Article: PLOS ONE. 2012;7(11):e50996The Adaptor Protein Grb2 Is Not Essential for the Establishment of the Glomerular Filtration BarrierBisson N; Ruston J; Jeansson M; Vanderlaan R; Hardy WR; Du J; Hussein SM; Coward RJ; Quaggin SE; Pawson T
- Article: DIABETES. 2012;61(11):2958-2966Sivaskandarajah GA; Jeansson M; Maezawa Y; Eremina V; Baelde HJ; Quaggin SE
- Article: CELL. 2012;151(2):384-399Jin J; Sison K; Li C; Tian R; Wnuk M; Sung H-K; Jeansson M; Zhang C; Tucholska M; Jones N; Kerjaschki D; Shibuya M; Fantus IG; Nagy A; Gerber H-P; Ferrara N; Pawson T; Quaggin SE
- Article: DEVELOPMENTAL BIOLOGY. 2012;367(1):40-54Cai Q; Brissova M; Reinert RB; Pan FC; Brahmachary P; Jeansson M; Shostak A; Radhika A; Poffenberger G; Quaggin SE; Jerome WG; Dumont DJ; Powers AC
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2011;121(6):2278-2289Jeansson M; Gawlik A; Anderson G; Li C; Kerjaschki D; Henkelman M; Quaggin SE
- Article: CELL METABOLISM. 2010;12(4):329-340Welsh GI; Hale LJ; Eremina V; Jeansson M; Maezawa Y; Lennon R; Pons DA; Owen RJ; Satchell SC; Miles MJ; Caunt CJ; McArdle CA; Pavenstädt H; Tavaré JM; Herzenberg AM; Kahn CR; Mathieson PW; Quaggin SE; Saleem MA; Coward RJM
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2009;119(4):943-953Crowley SD; Vasievich MP; Ruiz P; Gould SK; Parsons KK; Pazmino AK; Facemire C; Chen BJ; Kim H-S; Tran TT; Pisetsky DS; Barisoni L; Prieto-Carrasquero MC; Jeansson M; Foster MH; Coffman TM
- Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009;20(1):114-122Jeansson M; Bjorck K; Tenstad O; Haraldsson B
- Article: DIABETOLOGIA. 2006;49(9):2200-2209Jeansson M; Granqvist AB; Nystrom JS; Haraldsson B
- Article: EUROPEAN JOURNAL OF PHARMACOLOGY. 2006;539(3):184-191Gradin KA; Zhu H; Jeansson M; Simonsen U
- Article: AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. 2006;290(1):F111-F116Jeansson M; Haraldsson B
- Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14(7):1756-1765Jeansson M; Haraldsson B
- Visa fler
Alla övriga publikationer
- Preprint: BIORXIV. 2025Pietilä R; Genové G; Mocci G; Miao Y; Liu J; Leptidis S; Del Gaudio F; Uhrbom M; Vázquez-Liébanas E; Gustafsson S; Buyandelger B; Raschperger E; Björkegren JLM; Hansson E; Gaengel K; Mäe MA; Jeansson M; Vanlandewijck M; He L; Strell C; Peng X-R; Lendahl U; Betsholtz C; Muhl L
- Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024;39:gfae069-0742-2114Pietila R; Marks A; Betsholtz C; Jeansson M
- Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024;39:I1216Pietila R; Marks A; Betsholtz C; Jeansson M
- Preprint: PREPRINTS.ORG. 2024Zhou AX; Jeansson M; He L; Wigge L; Tonelius P; Tati R; Cederblad L; Muhl L; Uhrbom M; Liu J; Björnson Granqvist A; Lerman L; Betsholtz C; Laerkegaard Hansen P
- Preprint: MEDRXIV. 2024Koskinen M; Englund E; Korkut GG; Schwarz A; Jeansson M
- Conference publication: JOURNAL OF VASCULAR RESEARCH. 2023;60(SUPP1):48Pietila R; Nanavazadeh S; Economide AN; Koh GY; Quaggin SE; Betsholtz C; Jeansson M
- Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11):587Pietila RS; Quaggin SE; Betsholtz C; Jeansson M
- Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11S):587Pietilä RS; Quaggin SE; Betsholtz C; Jeansson M
- Conference publication: ACTA PHYSIOLOGICA. 2022;236:333Pietila R; Nanavazadeh S; Koh GY; Quaggin SE; Betsholtz C; Jeansson M
- Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10):240-241Zhou AX; Jeansson M; He L; Tonelius P; Muhl L; Uhrbom M; Liu J; Granqvist A; Lerman LO; Betsholtz C; Hansen PBL
- Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10):55Pietila RS; Quaggin SE; Betsholtz C; Jeansson M
- Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10S):55Pietilä RS; Quaggin SE; Betsholtz C; Jeansson M
- Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10S):240-241Zhou AX; Jeansson M; He L; Tonelius P; Muhl L; Uhrbom M; Liu J; Granqvist A; Lerman LO; Betsholtz C; Hansen PBL
- Preprint: MEDRXIV. 2021Hultström M; Fromell K; Larsson A; Quaggin S; Betsholtz C; Frithiof R; Lipcsey M; Jeansson M
- Conference publication: JOURNAL OF VASCULAR RESEARCH. 2021;58:3Pietila R; Nanavazadeh S; Koh GY; Quaggin SE; Betsholtz C; Jeansson M
- Conference publication: JOURNAL OF VASCULAR RESEARCH. 2021;58:5Hultstrom M; Fromell K; Larsson A; Quaggin SE; Betsholtz C; Frithiof R; Lipcsey M; Jeansson M
- Conference publication: ANNALS OF ONCOLOGY. 2017;28:ii12Sandelin M; Grudén S; Rasanen V; Micke P; Hedeland M; Axén N; Jeansson M
- Review: ANNUAL REVIEW OF PHYSIOLOGY. 2016;78:437-461Bartlett CS; Jeansson M; Quaggin SE
- Review: CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2011;20(3):258-262Singh SKS; Jeansson M; Quaggin SE
- Review: CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2009;18(4):331-335Haraldsson B; Jeansson M
Forskningsbidrag
- Angiopoietin-2 and Lipocalin-2 as causal factors of endothelial dysfunction and diabetic complicationsEXODIAB1 April 2025 - 31 March 2026
- Therapeutic intervention to slow progression of chronic kidney diseaseKnut och Alice Wallenbergs Stiftelse1 January 2025 - 31 December 2026
- Therapeutic intervention to slow progression of chronic kidney diseaseNovo Nordisk Foundation1 January 2024 - 31 December 2024
- European Foundation for the Study of Diabetes1 January 2024 - 31 December 2024
- Angiopoietin-2 och thrombosbildning i njuren vid COVID-19Njurfonden1 January 2023 - 31 December 2023
- Angiopoietin-2 och thrombosbildning i njuren vid COVID-19Njurfonden1 January 2022 - 31 December 2022
- Angiopoietiners roll vid fibrosibildningMagn. Bergwalls Stiftelse1 March 2015 - 29 February 2016
- The Angiopoietin/Tek System in Fibrotic DiseaseIGPs medel till Unga Forskare1 January 2015 - 31 December 2015
- Angiopoietin/Tek systemets roll vid fibrosutvecklingMagn. Bergwalls Stiftelse1 March 2014 - 28 February 2015
- Angiopoietin/Tek systemets roll vid fibrosutvecklingÅke Wiberg1 March 2014 - 28 February 2015
- Swedish Research Council1 January 2013 - 31 December 2015
- Discovery of new therapeutic targets in human disease through animal modelsVenture Sinai Women1 August 2012 - 31 July 2013
- Endothelial cell glycocalyx and vascular endothelia growth factor-A (VEGF-A) in the renal glomerular barrierWenner-Gren Stiftelserna1 January 2008 - 31 December 2008
- Growth Factor Signaling in Renal DiseaseVetenskapsrådet1 January 2008 - 31 December 2008
- The glomerular barrier and the endothelial cell glycocalyWenner-Gren Stiftelserna1 January 2007 - 31 December 2007
Anställningar
- Forskare, Medicin, Huddinge, Karolinska Institutet, 2018-
- Docent, Vaskulärbiologi, Immunology, Genetics, and Pathology, Uppsala University, 2017-2018
- Forskare, Vaskulärbiologi, Njursjukdom, Immunologi, Genetic, and Pathology, Uppsala University, 2013-2017
- Postdoctoral Fellow, Lunenfeld-Tanenbaum Research Institute, 2006-2013
Examina och utbildning
- Docent, Vasculärbiologi, Immunology, genetics, and Pathology, Uppsala University, 2017
- PhD, Njurfysiologi, Aspects of the glomerular barrier in healthy and diabetic kidneys, Neuroscience and Physiology, University of Gothenburg, 2005
- Medicine magisterexamen, Linnaeus University, 2001
Uppdrag
- Academic Mentor postdoctoral fellow, Roche Innovation Center, 2018-2020
Handledning
Handledning till doktorsexamen
- Yuyang Miao, 2021-
- Krishnapriya Loganathan, 2018
- Yang Zhang, Organ-specific mechanisms of vascular development in the mesentery, 2018
- Maria Ascencion Globisch, Inflammation and immunothrombosis in cerebral cavernous malformations, novel molecular targets for the treatment of an incurable disease, 2023
Handledning av postdoktorala forskare
- Amanda Marks, 2023-
Uppdrag i kommitté
- Medlem, American Society of Nephrology's PhD committee, American Society of Nephrology, 2016-2018
- Medlem, Committee for Equal Opportunities, Immunology, Genetics, and Pathology, Uppsala University, 2015-2018
- Medlem, Committee for Common Instruments, Immunology, Genetics, and pathology, Uppsala University, 2014-2018
Gästforskning och resestipendier
- Postdoktor, Mount Sinai Hospital, 2006-2013
- Postdoktor, University of Gothenburg, 2005-2006
Utvärdering av avhandlingsarbete
- Milena Petkova, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Cell-autonomous and paracrine mechanisms underlaying Pik3ca-driven vascular malformations, 2024
- Alessandra Vaccaro, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Tertiary lymphoid structures in glioblastoma, 2024
- Federico Cantoni, Examination board member, Department of Materials Science and Engineering, Uppsala University, Fabrication advances of microvasculature models on-chip, 2023
- Nina Daubel, Examination board member, Department of Immunology, Genetics, and Pathology, Uppsala University, Lymphatic vasculature morphogenesis: from progenitors to functional vessels, 2022
- Frida Olsson, Examination board member, Farmaceutisk Biovetenskap, Uppsala University, Half-time seminar: Studies of cellular signaling via pathways involving steroids and tyrosine kinase receptors, 2022
- Ana Maria Porras, Examination board member, Department of Materials Science and Engineering, Uppsala University, Micropatterning of hyaluronic acid hydrogels for in vitro models, 2022
- Balboa Amanda, Examination board member, Department of Medical Cell Biology, Uppsala University, Experimental mechanisms in aneurysms formation, 2022
- Minna Kihlström, External thesis reviewer, University of Oulu, Characterization of angiopoietin ligands: role of angiopoietin-4 in retinal venous development and angiopoietin-2 variant in tumor vasculature, 2019
- Minna Kihlström, External thesis reviewer, University of Oulu, Characterization of angiopoietin ligands: Role of angiopoietin-4 in retinal venous development and angiopoietin-2 variant in tumor vasculature, 2019
- Maria Georganaki, Examination board member, Department of Immunology, Genetics, and Pathology, Uppsala University, Vascular targeting for enhanced cancer immunotherapy, 2018
- Anja Nitzsche, Examination board member, Department of Immunology, Genetics, and Pathology, Uppsala University, The role of Paladin in endothelial cell signaling and angiogenesis, 2016
- Sofia Nordling, Examination board member, Immunology, Genetics, and pathology, Uppsala University, Vascular Interactions in Innate Immunity and Immunothrombosis, Models of Endothelial Protection, 2016
- Luuk van Hooren, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Half-time seminar, 2015
- Eric Morin, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Half-time seminar, 2015
Expert
- Reviewer of candidates proposed for academic positions, Sakkunningutlåtande för Docentur (Jessica Cedervall), Uppsala University, 2019-2019
- Other evaluation assignments, Kidney Week 2015 - Abstract reviewer, American Society of Nephrology, 2015-2015
- Other evaluation assignments, Abstract Reviewer, WCN Congress, Hong Kong, World Congress of Nephrology, 2013-2013
- Other evaluation assignments, Abstract Reviewer
- Gordon Research Conference, Endothelial Phenotypes in Health and Disease, Gordon Research Conferences, 2012-2012
Konferenser och events
- Muntliga presentationer av egna accepterade abstract, European Renal Association, Stockholm, Sweden, TIE2 activation promotes vascular protection of tubules to reduce PDGFB driven tubulointerstitial fibrosis in experimental chronic kidney disease«, 2024
- Inbjuden föredragshållare, pre-meeting European Renal Association, Uppsala, Sweden, TIE2 activation promotes vascular protection of tubules to reduce PDGFB driven tubulointerstitial fibrosis in experimental chronic kidney disease«, 2024
- Inbjuden föredragshållare, VascBio seminar
- Uppsala Unversity, Uppsala, Sweden, TIE-ing 2gether endothelial dysfunction and fibrosis in chronic kidney disease, 2024
- Inbjuden föredragshållare, Yale-Uppsala seminar, TIE2 activation as therapeutic intervention in chronic kidney disease (CKD), 2023
- Inbjuden föredragshållare, Clinical Immunology seminar
- Uppsala University, Uppsala, Sweden, Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients, 2021
- Inbjuden föredragshållare, SciLifeLab seminar, Uppsala, Elevated angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients, 2021
- Inbjuden föredragshållare, Seminar
- AstraZeneca, Gothenburg, Sweden, Tie2 signaling in chronic kidney disease, 2020
- Inbjuden föredragshållare, Seminar
- Integrated Cardio Metabolic Centre, Huddinge, Sweden, Endothelial-pericyte cross talk via Tie2 and Pdgfb affect capillary rarefaction and tubulointerstitial fibrosis in chronic kidney disease, 2019
- Inbjuden föredragshållare, Seminar, Renal medicine Baxter Novum, Angiopoietin-1 and Tie2 signaling in capillary rarefaction and CKD, 2019
- Muntliga presentationer av egna accepterade abstract, Kidney Week, American Society of Nephrology, Washington, DC, USA, Capillaries are Primary Targets in CKD and Loss of Tie2 Signaling Increases Vascular Injury, 2019
- Inbjuden föredragshållare, Presentation
- Karo Kidney meeting, Angiopoietin-1 and Tie2 signaling in capillary rarefaction and CKD, 2018
- Inbjuden föredragshållare, Symposia for Erik Ilso Christensen, Aarhus University, Myths and truths in tubular handling of albumin, 2018
- Inbjuden föredragshållare, IGP-day, Uppsala University, Sweden, 2018
- Ordförande, Kidney Week, American Society of Nephrology, New Orleans, Ordförande for the session: Diabetsity, still a big problem?, 2017
- Ordförande, Kidney Week, American Society of Nephrology, New Orleans, USA, Ordförande
- Diabesity, still a big problem?, 2017
- Inbjuden föredragshållare, Seminar
- AstraZeneca, Angiopoietin-1/Tie2 signaling in kidney fibrosis, 2017
- Inbjuden föredragshållare, VascBio Seminars series, Uppsala University, Angiopoietin-1 in tumor growth and metastasis, 2015
- Inbjuden föredragshållare, Bristol University, UK, Angiopoietins - the yin and yang of vascular diseases, 2014
- Inbjuden föredragshållare, Seminar
- Lunenfeld-Tannenbaum Research Institute, Toronto, Canada, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2013
- Inbjuden föredragshållare, Seminar
- Karolinska Institutet, Stockholm, Sweden, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2013
- Inbjuden föredragshållare, Seminar
- Uppsala University, Uppsala, Sweden, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2013
- Inbjuden föredragshållare, Seminar
- Sahlgrenska University Hospital, Gothenburg, Sweden, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2012
- Inbjuden föredragshållare, Lunenfeld-Tannenbaum Research Institute Annual Retreat, Geneva Park, Angiopoietin-1 in mouse vasculature, 2012
- Inbjuden föredragshållare, Experimental Biology, Physiology in Focus session. San Diego, Ca, USA., New advances in the pathophysiology and treatment of chronic glomerular diseases, 2012
- Ordförande, Gordon Research Seminars
- Endothelial Phenotypes in Health and Disease, 2012
- Inbjuden föredragshållare, Seminar
- Venture Sinai Women 2, Discovery of New Therapeutic Targets in Human Disease through Animal Models
- Future uses of Angiopoietin-1, 2012
- Inbjuden föredragshållare, Lunch Seminars
- Lunenfeld-Tannebaum Research institute, Toronto, Canada, Angiopoietin-1 is essential in mouse vasculature during development and in response to injury, 2011
- Muntliga presentationer av egna accepterade abstract, Renal Week, American Society of Nephrology, Denver, CO, USA, Multiple roles for Angiopoietin-1 in renal health and diseases, 2010
- Inbjuden föredragshållare, Renal Rounds, Toronto General Hospital, Toronto, Canada, Angiopoietins in diabetic nephropathy, 2010
- Inbjuden föredragshållare, Renal Week, American Society of Nephrology, San Diego, CA, USA, scientific session, 2009
- Muntliga presentationer av egna accepterade abstract, Renal Week, American Society of Nephrology, San Diego, CA, USA., Multiple roles for Angiopoietin-1 in health and disease, 2009
- Inbjuden föredragshållare, Renal Rounds
- Toronto general Hospital, Toronto, Canada, Angiopoietin-1 is critical for vascular development and renal repair in diabetes mellitus, 2009
- Inbjuden föredragshållare, Annual Retreat
- Samuel Lunenfeld Research Institute, Great Lakes, Canada, Angiopoietin-1 is critical for vascular development and renal repair in diabetes mellitus, 2009
- Inbjuden föredragshållare, Lunch seminar
- Lunenfeld-Tannenbaum Research Institute, Toronto, Canada, Angiopoietin-1 in glomerular function and the vasculature, 2008
- Inbjuden föredragshållare, Renal rounds, Toronto General Hospital, Toronto, Canada, Angiopoietin-1 in vascular development and glomerular function, 2008
- Inbjuden föredragshållare, Scandinavian Society of Nephrology, Gothenburg, Sweden, Functional properties of the glomerular barrier, 2007